Okay, let's tackle this question about drug-induced SLE and the associated antibody. The user wants a detailed explanation following specific formatting rules.

First, I need to recall which antibodies are characteristic of drug-induced SLE. I remember that antihistone antibodies are commonly associated with this condition. That's different from systemic lupus erythematosus (SLE) in general, which might have other antibodies like anti-dsDNA or anti-Smith.

Now, the core concept here is the distinction between drug-induced SLE and other types. Drug-induced SLE is often caused by medications like hydralazine, procainamide, or isoniazid. The key antibody here is antihistone antibodies. I need to make sure that's correct and explain why.

For the correct answer section, I'll explain that antihistone antibodies are specific for drug-induced SLE. They target histones, which are part of the nucleosome. These drugs might lead to the release of histones or interfere with their presentation, triggering an immune response.

Then, the wrong options: maybe they include anti-dsDNA (which is more for SLE), anti-Smith (also SLE-specific), and anti-SSA/SSB (seen in Sjögren's). Each of these needs a brief explanation of why they're not the answer here.

The clinical pearl should highlight the key difference between drug-induced and other types. Maybe mention that if a patient is on certain drugs and shows symptoms, checking for antihistone antibodies can help diagnose drug-induced SLE.

Need to keep each section concise, use bold terms, and stick to the character limit. Let me structure each part step by step without missing any required sections.

**Core Concept**
Drug-induced lupus erythematosus (DILE) is characterized by antihistone antibodies, distinguishing it from classic systemic lupus erythematosus (SLE), which typically features anti-dsDNA or anti-Smith antibodies. The pathogenesis involves drug-induced T-cell activation and altered antigen presentation, leading to autoantibody production.

**Why the Correct Answer is Right**
Antihistone antibodies are the hallmark of DILE, particularly in patients taking hydralazine, procainamide, or isoniazid. These drugs bind to histones, altering their structure and triggering an immune response. Histones are core proteins in chromatin, and their autoantibodies indicate immune cross-reactivity induced by drug-histone complexes.

**Why Each Wrong Option is Incorrect**
**Option A:** Anti-dsDNA antibodies are specific to classic SLE, not DILE.
**Option B:** Anti-Smith (Sm) antibodies are diagnostic of SLE but absent in DILE.
**Option C:** Anti-SSA/SSB antibodies are associated with Sjögren’s syndrome and neonatal lupus, not DILE.

**Clinical Pearl / High-Yield Fact**
Remember: **“Histones for hydralazine”** — antihistone antibodies are the key serologic marker in DILE. Discontinuing the offending drug usually resolves symptoms within months. Classic SLE antibodies (e.g., anti-dsDNA) are absent in DILE.

**Correct Answer: C. Antihistone antibodies**

✓ Correct Answer: A. Anti histone antibody